Chen et al. [24] reported that the expression of PPARγ was down-regulated in the conjunctiva of mice with dry eye, and they also found that pioglitazone, a synthetic PPARγ ligand, exerted therapeutic effects to increase tear fluid production and enhance tear film stability. This evidence concerns the gene PPARG and Keratoconjunctivitis sicca.